Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$93.4K Buy
72,971
+3,466
+5% +$4.88K ﹤0.01% 1860
2026
Q1
$104K Buy
+69,505
New +$106K ﹤0.01% 1678
2025
Q3
$79.8K Buy
+58,230
New +$77.5K ﹤0.01% 1377

Other funds holding GERN

CIBC Bancorp USA's GERN Position: Q2 2026 in Review

CIBC Bancorp USA increased its Geron (GERN) stake by 5% in Q2 2026, buying an estimated $4.88K and bringing the position to 72,971 shares worth $93.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1860.

CIBC Bancorp USA first reported a position in GERN in Q3 2025 and has held it in 3 quarters since. The position peaked at $104K in Q1 2026. 247 funds tracked by Wall St. Rank hold GERN as of Q2 2026.

  • CIBC Bancorp USA held 72,971 shares of Geron worth $93.4K as of Q2 2026.
  • CIBC Bancorp USA bought 3,466 Geron shares in Q2 2026, an estimated $4.88K.
  • Geron made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1860 holding.
  • CIBC Bancorp USA first reported a position in Geron in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Geron position peaked at $104K in Q1 2026.
  • 247 funds tracked by Wall St. Rank held Geron as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.